GUIDOR

Morges, Switzerland Founded: 2004 • Age: 22 yrs Acquired By Collagen Matrix
Synthetic bone graft products are developed for tissue regeneration.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About GUIDOR

GUIDOR is a company based in Morges (Switzerland) founded in 2004 was acquired by Collagen Matrix in December 2020. GUIDOR operates in a competitive market with competitors including Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.

  • Headquarter Morges, Switzerland
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare β†’ Healthcare Products & Supplies → Unlock Sub-Sector → Unlock Segment
Healthcare β†’ Pharmaceuticals & Therapeutics → Unlock Sub-Sector → Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Collagen Matrix

    (Dec 29, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of GUIDOR

Premium access

Detailed funding history for GUIDOR

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in GUIDOR

GUIDOR has secured backing from 1 investor. Prominent investors backing the company include Collagen Matrix.

All
InvestorDescriptionFounded YearDomainLocation
Collagen and mineral based medical devices
LockedLockedLocked
Premium access

Investor details for GUIDOR

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by GUIDOR

Investments
Premium access

Investment portfolio details for GUIDOR

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - GUIDOR

Premium access

Detailed financials for GUIDOR

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Guidor Comparisons

GUIDOR Primary company
Description
Synthetic bone graft products are developed for tissue regen...
Location
Morges, Switzerland
Founded Year
2004
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for GUIDOR

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of GUIDOR

GUIDOR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.

Company NameDomainFounded yearHQ LocationDescription
LockedLockedLocked
Therapeutic delivery platform is developed for orthopedic clinical indications.
LockedLockedLocked
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
LockedLockedLocked
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
LockedLockedLocked
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
LockedLockedLocked
Synthetic adhesives for bone and dental repair are developed.
LockedLockedLocked
Developer of stem cells to regrow damaged bones
Premium access

Detailed competitors of GUIDOR

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Guidor

Premium access

Complete news archive for GUIDOR

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GUIDOR

GUIDOR was founded in 2004.

GUIDOR is headquartered in Morges, Switzerland. It is registered at Morges, Vaud, Switzerland.

Shawn McCarthy is the current CEO of GUIDOR.

Founded in 2004 and based in Morges, Switzerland, synthetic bone graft products are developed by the company for bone tissue regeneration in the biomedical sector. A biomaterial is provided that applies directly from a syringe to form porous scaffolds supporting clot stability during early healing. Osteoconductive grafts are offered to stabilize sites, maintain clots, and enable new bone growth. Periocline dental ointment is also supplied for periodontal disease treatment.

GUIDOR's top competitors include EpiBone, Theradaptive and MiMedx Group.

GUIDOR has 1 investor. Key investors include Collagen Matrix.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available